Terms: = Leukemia AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Staging
98 results:
1. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
Kutluk T; Sahin B; Kirazli M; Ahmed F; Aydin S; Yesil Çinkir H; Sezgin G; Bayram I; Ebinç S; Isikdogan A; Sasmaz I; Okan V; Ilhan G; Ören AC; Akbayram S; Harputluoglu H; Ural C; Ayyildiz O; Aktas G; Uçar MA; Güvenç B; Köse D; Acipayam C; Güncan S; Erçolak V; Berber I; Akdeniz A; Akyay A; Üzel VH; Söker M; Sengelen M; Yalçin S; Sullivan R
JAMA Netw Open; 2023 May; 6(5):e2312903. PubMed ID: 37219908
[TBL] [Abstract] [Full Text] [Related]
2. [De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
Matsunaga T; Naganuma K; Tabayashi T; Kawada T; Sakata N; Takahashi Y; Kimura Y; Anan T; Mitsuhashi T; Kubota Y; Sawada K; Yamashita T; Momose S; Higashi M; Tamaru JI; Kizaki M
Rinsho Ketsueki; 2022; 63(12):1643-1647. PubMed ID: 36653137
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic leukemia in Sudanese Population.
Basabaeen AA; Abdelgader EA; Ahmed EB; Abdelateif NM; Osman Abdelrahim S; Sharif OM; Altayeb OA; Fadul EA; Osman Ibrahim I
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3229-3235. PubMed ID: 36172689
[TBL] [Abstract] [Full Text] [Related]
4. Lymphoblastic Lymphoma: a Concise Review.
Intermesoli T; Weber A; Leoncin M; Frison L; Skert C; Bassan R
Curr Oncol Rep; 2022 Jan; 24(1):1-12. PubMed ID: 35059993
[TBL] [Abstract] [Full Text] [Related]
5. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Schjesvold FH; Dimopoulos MA; Delimpasi S; Robak P; Coriu D; Legiec W; Pour L; Špička I; Masszi T; Doronin V; Minarik J; Salogub G; Alekseeva Y; Lazzaro A; Maisnar V; Mikala G; Rosiñol L; Liberati AM; Symeonidis A; Moody V; Thuresson M; Byrne C; Harmenberg J; Bakker NA; Hájek R; Mateos MV; Richardson PG; Sonneveld P;
Lancet Haematol; 2022 Feb; 9(2):e98-e110. PubMed ID: 35032434
[TBL] [Abstract] [Full Text] [Related]
6. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial.
Usmani SZ; Hoering A; Ailawadhi S; Sexton R; Lipe B; Hita SF; Valent J; Rosenzweig M; Zonder JA; Dhodapkar M; Callander N; Zimmerman T; Voorhees PM; Durie B; Rajkumar SV; Richardson PG; Orlowski RZ;
Lancet Haematol; 2021 Jan; 8(1):e45-e54. PubMed ID: 33357482
[TBL] [Abstract] [Full Text] [Related]
7. [Evolvement of a five-way translocation t(5;9;22;6;17) from a four-way Philadelphia translocation t(5;9;22;6) in a rare case of chronic myeloid leukemia].
Kong S; Gu Y; Qin Y; Wang Z; Feng L; Jiang Q; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1395-1398. PubMed ID: 33306831
[TBL] [Abstract] [Full Text] [Related]
8. T cell lymphoma in the setting of Sjögren's syndrome: T cells gone bad? Report of five cases from a single centre cohort.
Stergiou IE; Papageorgiou A; Chatzis LG; Tzioufas AG; Voulgarelis M; Goules A
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):125-129. PubMed ID: 33025901
[TBL] [Abstract] [Full Text] [Related]
9. Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience.
Zahran AM; Moeen SM; Thabet AF; Rayan A; Abdel-Rahim MH; Mohamed WMY; Hetta HF
Leuk Lymphoma; 2020 Jul; 61(7):1645-1652. PubMed ID: 32077360
[TBL] [Abstract] [Full Text] [Related]
10. Productivity of 18F-FDG-PET/CT Diagnostic Tool in the Management of Pediatric Lymphoblastic Lymphoma.
Elhussein A; Fawzy M; Abdel Rahman H; Omar W; Hussein EM
Nucl Med Rev Cent East Eur; 2019; 22(1):23-28. PubMed ID: 31482539
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical Features and Prognosis of 35 Children with Burkitt Lymphoma/leukemia].
Zheng YZ; LE SH; Zheng H; Hua XL; Chen ZS; Zheng L; Chen C; Li M; Cai CX; Yang JH; Chen YQ; Gao QL; Chen YY; Li J; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1123-1130. PubMed ID: 31418367
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical Study of SCIN Expression and Dromoter Methylation in Patients with Chronic Myeloid leukemia].
Zhang ZH; Lian XY; Li XX; He PF; Lin J; Qian J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):646-651. PubMed ID: 31204912
[TBL] [Abstract] [Full Text] [Related]
13. High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for staging.
Acuna-Villaorduna A; Gonzalez-Lugo J; Ye BH; Adrianzen Herrera DA; Sica RA; Shah U; Shah N; Kornblum N; Braunschweig I; Derman O; Mantzaris I; Shastri A; Wang Y; Verma A; Zalta B; Janakiram M
Leuk Lymphoma; 2019 Dec; 60(13):3272-3276. PubMed ID: 31204876
[TBL] [Abstract] [Full Text] [Related]
14. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia.
Patel A; Tiwari A; Biswas B; Chand Sharma M; Vishnubhatla S; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e291-e298. PubMed ID: 30905539
[TBL] [Abstract] [Full Text] [Related]
16. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic leukemia.
Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
[No Abstract] [Full Text] [Related]
17. Pediatric Malignant Mediastinal Masses.
Kashif RU; Faizan M; Anwar S
J Coll Physicians Surg Pak; 2019 Mar; 29(3):258-262. PubMed ID: 30823954
[TBL] [Abstract] [Full Text] [Related]
18. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
Casasnovas RO; Bouabdallah R; Brice P; Lazarovici J; Ghesquieres H; Stamatoullas A; Dupuis J; Gac AC; Gastinne T; Joly B; Bouabdallah K; Nicolas-Virelizier E; Feugier P; Morschhauser F; Delarue R; Farhat H; Quittet P; Berriolo-Riedinger A; Tempescul A; Edeline V; Maisonneuve H; Fornecker LM; Lamy T; Delmer A; Dartigues P; Martin L; André M; Mounier N; Traverse-Glehen A; Meignan M
Lancet Oncol; 2019 Feb; 20(2):202-215. PubMed ID: 30658935
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract] [Full Text] [Related]
20. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.
Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies F; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan G
Leukemia; 2019 Jan; 33(1):159-170. PubMed ID: 29967379
[TBL] [Abstract] [Full Text] [Related]
[Next]
